| Outcome Measures: |
Primary: Change in HbA1c, Measured in percentage (%)-points, From baseline (week 0) to End of Study visit (V3) (week 34-44) | Secondary: Relative change in body weight, Measured in percentage (%), From baseline (week 0) to End of Study visit (V3) (week 34-44)|Absolute change in body weight, Measured in Kilogram (Kg), From baseline (week 0) to End of Study visit (V3) (week 34-44)|HbA1c < 7%, Measured as Yes or No, End of Study visit (V3) (week 34- 44)|HbA1c reduction >=1%-points and body weight reduction of >=5%, Measured as Yes or No, From baseline (week 0) to End of Study visit (V3) (week 34-44)|HbA1c reduction >=1%-points and body weight reduction of >=3%, Measured as Yes or No, From baseline (week 0) to End of Study visit (V3) (week 34-44)|DTSQc, relative treatment satisfaction, Measured in Total score, End of Study visit (V3) (week 34- 44)|DTSQs, change in absolute treatment satisfaction, Measured in Total score, From baseline (week 0) to End of Study visit (V3) (week 34-44)
|
